MedTrace Logo

Monitoring Heart Rate Variability for the Early Detection of Pancreatic Cancer

NCT04400903 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2022-11-22

No results posted yet for this study

Summary

This study examines heart rate monitoring variability for the early detection of pancreatic cancer. Pancreatic cancer is a very difficult disease to detect early. This study is being done to observe the heart rate variability in patients with pancreatic cancer compared to undiagnosed individuals with increased risk of developing pancreatic cancer. This may help researchers determine if pancreatic occurrences/recurrences (chance of coming back) can be detected sooner through monitoring heart rate and activity.

Conditions

Interventions

DEVICE

Activity Monitor

Undergo HRV monitoring via WHOOP device

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Complete questionnaires

Sponsors & Collaborators

  • Oregon Health and Science University

    collaborator OTHER

  • American Association for Cancer Research

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • OHSU Knight Cancer Institute

    lead OTHER

Principal Investigators

  • Aaron Grossberg · OHSU Knight Cancer Institute

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-21
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04400903 on ClinicalTrials.gov